N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.26 NOK -0.44% Market Closed
Market Cap: 738m NOK

Intrinsic Value

The intrinsic value of one NYKD stock under the Base Case scenario is hidden NOK. Compared to the current market price of 2.26 NOK, Nykode Therapeutics ASA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NYKD Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Nykode Therapeutics ASA

Intrinsic Value History
Dive into the past to invest in the future

NYKD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NYKD usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NYKD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NYKD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Nykode Therapeutics ASA.

Explain Valuation
Compare NYKD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NYKD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nykode Therapeutics ASA

Current Assets 67m
Receivables 3m
Other Current Assets 64m
Non-Current Assets 39m
PP&E 6.2m
Intangibles 70k
Other Non-Current Assets 32.7m
Current Liabilities 3.9m
Other Current Liabilities 3.9m
Non-Current Liabilities 2.5m
Long-Term Debt 1.6m
Other Non-Current Liabilities 920k
Efficiency

Free Cash Flow Analysis
Nykode Therapeutics ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nykode Therapeutics ASA

Revenue
6.8m USD
Operating Expenses
-33.3m USD
Operating Income
-26.5m USD
Other Expenses
15.5m USD
Net Income
-11m USD
Fundamental Scores

NYKD Profitability Score
Profitability Due Diligence

Nykode Therapeutics ASA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Nykode Therapeutics ASA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NYKD Solvency Score
Solvency Due Diligence

Nykode Therapeutics ASA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Nykode Therapeutics ASA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 5.46 NOK with a low forecast of 2.22 NOK and a high forecast of 8.93 NOK.

Lowest
Price Target
2.22 NOK
2% Downside
Average
Price Target
5.46 NOK
141% Upside
Highest
Price Target
8.93 NOK
295% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NYKD is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one NYKD stock?

The intrinsic value of one NYKD stock under the Base Case scenario is hidden NOK.

Is NYKD stock undervalued or overvalued?

Compared to the current market price of 2.26 NOK, Nykode Therapeutics ASA is hidden .

Back to Top